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which are often not easy to achieve in many supramolecular 
hydrogels. [ 5,7 ] 
 The regeneration of tissue complexes, where the intimate 
integration between different adjacent tissue types plays a key 
role in their function, has been a long-standing challenge in 
the fi eld of tissue engineering. For example, well-integrated 
bone–cartilage complex is essential for the function of joints. 
Such structural complexity posts a signifi cant technical barrier 
to tissue engineers. [ 11,12 ] A scaffold designed to regenerate one 
specifi c tissue type is unlikely optimal for regenerating another 
tissue type, and therefore often fails to regenerate a functional 
multi-tissue complex. [ 12,13 ] 
 The transient nature of certain supramolecular interac-
tions allows a hydrogel to self-heal or self-integrate, i.e., sepa-
rate hydrogel pieces can be joined to form an integrated con-
struct. [ 6,7,14 ] Previous reports on self-healing materials focused 
on the role of self-healing property in extending the service 
life of structural materials, which are neither biocompatible 
nor biodegradable/erodible. [ 15 ] We hypothesize that a supra-
molecular hydrogel with a rapid self-integrating property may 
provide a novel solution to the regeneration of tissue complexes 
if it is biocompatible and biodegradable or erodible. In such 
an approach, separate pieces of a hydrogel, each carrying the 
respective cell types and signaling biomolecules, can be inte-
grated into a two- or multiple-tissue construct, where the com-
ponent tissues are regenerated in spatially defi ned regions and 
seamlessly integrated at their interfaces. 
 To achieve the above-mentioned goal, the ideal hydrogel 
should be able to rapidly self-integrate in its fully gelled form 
without any external intervention. We, therefore, developed 
a novel rapid self-integrating and shear-thinning hydrogel by 
grafting a signifi cant number of multiple-hydrogen-bond units 
on a biocompatible hydrophilic polymer ( Scheme  1 a), and 
investigated the regeneration of a cartilage–bone tissue complex 
in vivo using the novel hydrogel and a subcutaneous implanta-
tion model in nude mice (Scheme  1 b). 
 The chosen multiple-hydrogen-bond unit is a quadruple 
hydrogen-bond array named UPy (Ureido-pyrimidinone) 
because it has a dramatically higher intermolecular bonding 
strength than a single hydrogen bond. [ 16 ] The chosen polymer 
is dextran (DEX) because it is an FDA approved polysaccharide 
and has numerous functional groups to allow the intended 
covalent grafting of many UPy units along the DEX backbone. 
Utilizing the hydroxyl groups on DEX, we grafted many UPy 
units onto DEX to form the UPy-bearing polymers (Supporting 
Information, Scheme S1). The UPy graft density could be con-
trolled simply by changing the feeding ratio of UPy to dextran. 
 1 H NMR analysis was carried out to confi rm the structure of 
the DEX-UPy and the UPy-dimmer formation (Supporting 
 Hydrogels are increasingly used as tissue-engineering scaffolds 
and drug carriers. [ 1,2 ] Compared to porous scaffolding materials, 
hydrogels are appealing in fi lling irregular tissue defects due 
to their pre-gelling fl uidity, which circumvents the pre-shaping 
and invasive surgery. Traditional hydrogels are usually made by 
using reactive chemical reagents or applying ultra-violet (UV) 
light to form permanent covalent crosslinks between hydro-
philic polymers in an aqueous solution. The process and chem-
icals might harm cells and delicate biological substances, [ 3 ] and 
the resulting stable hydrogels lose the fl uidity and cannot be 
reshaped. 
 In contrast to the formation of covalent crosslinks, supra-
molecular hydrogels self-assemble via cooperative and highly 
specifi c physical interactions that transiently crosslink the 
hydrophilic polymer chains. [ 4–8 ] The transient supramolecular 
crosslinks can temporally be interrupted by an external stim-
ulus (such as a mechanical force) and can rebuild after the 
removal of the stimulus. This unique characteristic brings 
about the shear-thinning property (viscosity decreases with 
an increasing rate of shear stress) and thus allows the formed 
hydrogel to be injectable. [ 5,9 ] Therefore, shear-thinning hydro-
gels offer benefi ts over other hydrogels in that the already 
formed gel can be injected and can recover the gel state in a dif-
ferent shape (a defect or mold) after injection, which prevents 
the cells from sedimentation as in liquid gel precursors or/and 
loss of the biomolecules through leakage. [ 8–10 ] 
 Despite the potential advantages of mild processing condi-
tions and shear-thinning property, supramolecular hydrogels 
have not been widely used in tissue engineering. [ 5,6,8 ] Scaf-
folding materials for tissue engineering have to be biocompat-
ible and are desired to degrade/erode in a proper time period, 
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Information, Figure S1). The density of substitution (DS, the 
number of UPy units per 100 glucose units) was estimated by 
calculating the ratio of the areas under the characteristic peaks. 
 The multifunctionalized DEX-UPy polymer could form a 
robust hydrogel when the UPy density was suffi ciently high. 
For example, DEX-UPy2 (DS 5.5, 10% w/w) could be dissolved 
in water at elevated temperature (around 70 °C) and form a 
stable hydrogel after being cooled down to room temperature 
( Figure  1 a, panel 3), while pure DEX and DEX-UPy with a very 
low DS (DEX-UPy1, DS 2.8, 10% w/w) formed clear solutions 
under the same conditions (Figure  1 a, panels 1 and 2). Poly-
mers with too high a density of substitution (DS ≥ 8.1) had poor 
water solubility and thus could not be used for hydrogel prepa-
ration. With an appropriate UPy content, a DEX-UPy polymer 
could form a hydrogel, be loaded into a syringe, and be sub-
sequently injected through a needle (Figure  1 a, panel 4). The 
hydrogel behaved like a liquid under the shear stress during 
injection and quickly solidifi ed after the injection, which is a 
shear-thinning behavior. Different shapes of the hydrogel could 
be fabricated by injecting it into differently shaped molds. To 
illustrate the self-integration capacity, the hydrogel disks were 
cut into different parts and subsequently brought together. One 
hydrogel was dyed with rodamine (pink) and the other was 
left with the original color (light yellow) to examine the inte-
gration between the hydrogel pieces. The hydrogel was found 
to integrate within minutes after they were brought into con-
tact (Figure  1 b). Different patterns could be achieved, such as 
a rod of joined disks and an integrated disk consisting of an 
inner core and an outer ring. Previously, a telechelic PEG-
based co-polymer was functionalized with UPy at their two 
ends, and such modifi ed PEG was shown to form a hydrogel 
and used for protein delivery. [ 17 ] However, hydrogel forma-
tion of this polymer required hydrophobic segments and urea 
groups, which help the nanofi ber formation to stabilize the 
gel. While the PEG-UPy hydrogels were able to self-heal mac-
roscopically, the process took days because of the slow kinetics 
of the nanofi ber re-formation at the interface (see Basting 
et al., on page 7 of the Supporting Information), [ 18 ] and there-
fore not able to quickly integrate into a stable 3D structure for 
our aimed tissue repair/regeneration applications. 
 In order to quantify the mechanical properties associated 
with shear-thinning and the subsequent recovery, we meas-
ured the rheological properties of the hydrogels. A hydrogel 
made of a 10% (w/w) DEX-UPy (DS 5.5) polymer solution 
had a storage modulus of 170 Pa, whereas the hydrogel made 
of the same polymer with a concentration of 12.5% (w/w) had 
a storage modulus of 700 Pa ( Figure  2 a), showing the non-
linear relationship between the polymer concentration and 
the mechanical properties of such a polymer. To mimic the 
change from the statically stored gel to the mechanical injec-
tion of the gel from a syringe, a shear force was applied to 
the hydrogel with a 10% polymer concentration. At a critical 
shear stress level the hydrogel yielded and lost its mechanical 
integrity, where the storage modulus ( G′ ) fell below the loss 
modulus ( G″ ) (Figure  2 b). This phenomenon demonstrates 
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 Scheme 1.  Design of a DEX-UPy hydrogel for multitissue complex regen-
eration. a) Schematic illustration of DEX-UPy hydrogel formation and 
the mechanisms of the shear-thinning and self-recovery properties. Top: 
multiple hydrogen bonds of UPy and their dynamic interactions. Bottom: 
hydrogel network formation through UPy hydrogen bonds, the shear-
thinning under shear stress and self-recovering of the hydrogel. b) Sche-
matic illustration of self-integration and the application in cartilage–bone 
tissue complex regeneration. Hydrogels encapsulating chondrocytes 
(blue) and BMSCs/BMP-2 (red) were integrated into a construct and then 
implanted subcutaneously in a nude mouse to form the cartilage–bone 
tissue complex.
 Figure 1.  Formation of DEX-UPy hydrogel, its injectability, and self-inte-
grating property. a) Gel-forming property of dextran (DEX) polymers with 
different UPy substitution densities (DS). DEX with no modifi cation or 
with low UPy DS (DS 2.8, 10% w/w) was in a solution state, while a 
DEX-UPy polymer with an appropriate UPy DS (DS 5.5, 10% w/w) readily 
formed a hydrogel at room temperature and could be injectable through 
a 26G needle. b) Self-integration of the hydrogel pieces to form various 
structures. Some hydrogel disks were dyed pink with rodamine and the 
others were left with the original light yellow color to visualize the inter-
faces. Scale bar = 5 mm.











the shear-thinning property. Furthermore, cyclic high and low 
stresses were applied to the hydrogel. At a low stress level, the 
gel remained stable and the  G ′ was higher than  G″ . At a high 
stress level the gel changed into a liquid-like state with the 
 G ′ lower than  G ″. Upon removal of the high stress, the mate-
rial recovered its gel property within seconds (Figure  2 c). The 
hydrogel could be shear-thinned and recovered for many cycles 
without signifi cant loss of the mechanical properties. The 
thermal stability of the hydrogel was examined by measuring 
the rheological properties of the hydrogel against the tempera-
ture (Figure  2 d). The hydrogel was softened while being heated 
at a rate of 2 °C min −1 from room temperature, but it main-
tained the gel state even at 70 °C, which was the temperature 
when the polymer was initially dissolved in water. 
 When a hydrogel is used as a scaffold for tissue engineering, 
it serves as a temporary template and therefore is desired to 
degrade or erode in vivo. DEX is known not to be degradable by 
human enzymes. Therefore, covalently crosslinked DEX hydro-
gels are not degradable in the human body unless degradable 
bonds are incorporated into the crosslinkers. [ 19 ] The DEX-UPy 
hydrogel disintegrated over time mainly through physical ero-
sion, during which the hydrophilic polymer molecules disas-
sociated from one another and diffused into the aqueous envi-
ronment. The hydrogel with a concentration of 10% and a UPy 
content of 5.5% lost its ≈20% mass during the fi rst day and 
additional ≈35% over a month, while the hydrogel with a con-
centration of 12.5% and the same UPy content eroded slower 
and lost ≈45% mass in the entire time period (Supporting 
Information, Figure S2). The erosion profi le of this hydrogel 
can be adjusted to be suitable for engineering different tissue 
types, where a temporary template is typically needed for weeks 
to months. 
 Drugs or proteins could be encapsulated in the hydrogel 
and released over time in durations from days to months 
(Supporting Information, Figure S3), which is dependent 
on the size and characteristics of the drug or protein. Doxy-
cycline was used as a model drug of small molecules, and 
it was nearly completely released in vitro during the fi rst 
week. Since most growth factors for tissue morphogenesis 
are protein-based, we also encapsulated a model protein, 
bovine serum albumin (BSA), in the hydrogels and measured 
the release kinetics. BSA could be released for more than a 
month and there was no signifi cant burst release (only about 
10% of BSA was released during the fi rst day). A sustained 
release was achieved for BSA during the entire experimental 
duration of 4 weeks. Such a sustained release profi le for pro-
teins/growth factors is highly desired for tissue engineering 
applications. [ 2,20 ] 
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 Figure 2.  The rheological properties of DEX-UPy hydrogels. a) The frequency spectra of the dynamic moduli of DEX-UPy (DS 5.5) hydrogels with con-
centrations of 12.5% and 10% w/w, where a constant stress 0.1 Pa was applied. b) Dynamic modulus of 10% w/w hydrogel under increasing stress. 
Note the hydrogel yielded at a critical stress, corresponding to the state of being injected through a needle. c) The dynamic modulus of hydrogel (DS 
5.5, 10% w/w) under cyclic high (100 Pa) and low (0.1 Pa) stresses. Under the low stress DEX-UPy behaved like a gel, while it turned into a sol state 
under the high stress. Gel state was instantly recovered after the removal of the high stress. d) Change of the dynamic modulus of the hydrogel (DS 
5.5, 10% w/w) with temperature. The modulus decreased upon heating, however remained in the gel state even at 70 °C.











N  The DEX-UPy hydrogel remained a vis-
cous liquid for minutes after being cooled 
down to room temperature; thus, it was 
possible to mix and encapsulate cells in the 
hydrogel. Different types of cells, including 
chondrocytes and bone marrow stem cells 
(BMSCs), were individually encapsulated and 
cultured in the hydrogel. Under a confocal 
microscope, uniform cell distribution in each 
hydrogel was observed (Supporting Infor-
mation, Figure S4). The live-dead assay con-
fi rmed that both chondrocytes and BMSCs 
maintained a high viability in the hydrogel as 
examined after in culture for 2 weeks (Sup-
porting information, Figure S4), indicating 
that the DEX-UPy hydrogel is highly compat-
ible with mammalian cells. 
 Due to the injectability and self-integrating 
property of DEX-UPy hydrogel, we were able 
to fabricate a self-integrated scaffold to engi-
neer bone–cartilage tissue complex. Chon-
drocytes for cartilage formation and BMSCs 
plus bone morphogenetic protein 2 (BMP-2) 
for bone regeneration were encapsulated sep-
arately into two vials of the hydrogel (Figure 
S5, Supporting Information). Each cell-
encapsulated gel was subsequently injected 
into one side of a circular disk-shaped poly-
dimethylsiloxane (PDMS) mold separated 
by a Tefl on fi lm. Without external interven-
tion, intimate integration of the two com-
ponents was achieved immediately after the 
baffl e fi lm was removed. The self-integrated 
hydrogel construct was subcutaneously 
implanted in a nude mouse to evaluate the 
potential of osteochondral tissue complex 
regeneration. Three groups of cell–gel con-
structs were implanted, including chondro-
cytes alone, BMSCs/BMP-2, and self-inte-
grated constructs with the two types of cells 
encapsulated on two sides of the gel disk. 
The tissue formation was examined histologi-
cally after 8 weeks of implantation. Positive 
staining of mineralized tissue (Alizarin red, 
for bone) and sulfated glycosaminoglycan 
(Alcian blue, for cartilage) in the histological 
sections validated the formation of cartilage 
and bone within the single cell-type groups, 
respectively ( Figure  3 a,b). The results dem-
onstrate the capability of the new hydrogel in supporting the 
growth of both bone and cartilage tissues. The self-integrated 
osteochondral implants were stained using both Alcian blue 
and Alizarin red (Figure  3 c). Both bone and cartilage tissues 
were identifi ed within their spatially defi ned regions. While 
the chondrocytes side (left) was stained positive for cartilage 
only, the BMSCs/BMP-2 side (right) was stained positive for 
bone only. The regenerated cartilage and bone tissues were inti-
mately integrated as shown in the magnifi ed image (Figure  3 d). 
We quantifi ed the volumes of cartilage and bone tissues using 
ten sections from four different samples (Figure  3 e). Cartilage 
occupied a larger volume (≈70%) than bone (≈30%). Several 
studies have shown that co-culture of BMSCs with chondro-
cytes, either in a mixture or in close contact, would induce the 
differentiation of BMSCs to chondrocytes. [ 21 ] We suspected that 
some BMSCs at the interface region was induced into chon-
drocytes, therefore resulting in cartilage formation across the 
original boundary, leading to more cartilage than bone forma-
tion and the seamless integration between these two types of 
tissues. If it is desired to generate equal volumes of bone and 
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 Figure 3.  Subcutaneous implantation of the cell-gel constructs. a) A section of BMSCs/BMP-2 
only group, stained with Alizarin red (positive staining represents mineralized bone tissue). 
b) A section of chondrocytes only group, stained with Alcian blue (positive staining represents 
cartilage tissue). c) A section of the self-integrated group, stained with both Alizarin red and 
Alcian blue. d) A magnifi ed image of the interface region of image (c). e) Quantifi cation of 
bone and cartilage volumes using an image analysis software (Adobe Photoshop). There was 
signifi cantly more cartilage (≈70%) than bone (≈30%) in volume after subcutaneous implanta-
tion for 8 weeks. Scale bar = 5 mm in (a), (b), and (c); scale bar = 100 um in (d).
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cartilage, a smaller initial volume of chondrocyte-containing 
hydrogel could be used to counter balance the additional chon-
drocytes induced from BMSCs at the interface. 
 In summary, we have successfully developed a novel inject-
able (shear-thinning) and self-integrating hydrogel that is bio-
compatible, bioerodible and capable of releasing biomolecules 
sustainably. The cartilage–bone tissue complex was successfully 
regenerated in a subcutaneous implantation model using the 
self-integrating hydrogel with the selected cells and biomole-
cules. We have proved the concept of engineering a multitissue 
complex using the novel supramolecular hydrogel with shear-
thinning and self-integrating properties. The hydrogel may also 
be utilized to regenerate other tissue complexes by combining 
different types of cells and biomolecules. 
 Supporting Information 
 Supporting Information is available from the Wiley Online Library or 
from the author. 
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